This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roth, S. Articles by Pescovitz, O. H. Search for Related Content PubMed PubMed Citation Articles by Roth, S. Articles by Abernathy, M. P. Articles by Lee, W.-H. Articles by Pratt, L. Articles by Denne, S. Articles by Golichowski, A. Articles by Pescovitz, O. H. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Diabetes and Pregnancy High Risk Pregnancy Social Bookmarking                         What's this?

Insulin-Like Growth Factors I and II Peptide and Messenger RNA Levels in Macrosomic Infants of Diabetic Pregnancies

Mary Pell Abernathy, MD

Wei-Hua Lee, MD,PhD

Linda Pratt, BS

Scott Denne, MD

Departments of Obstetrics and Gynecology, Pediatrics, and Physiology and Biophysics, Indiana University School of Medicine, Indianapolis, Indiana

Alan Golichowski, MD,PhD

Departments of Obstetrics and Gynecology, Pediatrics, and Physiology and Biophysics, Indiana University School of Medicine, Indianapolis, Indiana; Department of Obstetrics and Gynecology, Indiana University School of Medicine, University Hospital Room 2440, 550 North University Boulevard, Indianapolis, IN 46202

Ora Hirsch Pescovitz, MD

Departments of Obstetrics and Gynecology, Pediatrics, and Physiology and Biophysics, Indiana University School of Medicine, Indianapolis, Indiana

Objective: Fetal macrosomia is a common complication of maternal diabetes mellitus and is associated with substantial morbidity, but the precise cellular and molecular mechanisms that induce fetal macrosomia are not well understood. We hypothesized that the macrosomia or accelerated fetal growth seen in infants of diabetic mothers is due to a perturbation of a putative placental-fetal growth axis involving growth hormone and insulin-like growth factors. Insulin-like growth factors I and II (IGF-I and IGF-II) are ubiquitous peptides that share structural homology with insulin and have been implicated in processes that control fetal growth. Studies of IGF levels in pregnancies complicated by diabetes and macrosomia have shown conflicting results. We set out to resolve these inconsistencies using molecular techniques to measure the placental IGF-I and IGF-II messenger RNA levels in placentas and a specific radioimmunoassay to measure IGF-I and IGF-II peptide levels in cord serum of normal and diabetic pregnancies.

Methods: Placentas and cord blood were collected immediately after delivery at term from patients from each of three study groups: 1) nonmacrosomic infants of nondiabetic mothers (controls), 2) macrosomic infants of diabetic mothers, and 3) nonmacrosomic infants of diabetic mothers. Both IGF-I and IGF-II levels were measured in cord serum and placental tissue by a specific radioimmunoassay. Total RNA was extracted and analyzed by Northern gels hybridized to IGF-I or IGF-II riboprobes.

Results: Levels of IGF-I in cord serum from the macrosomic diabetic group (83 ± 4.2 ng/mL) were significantly higher than levels from either the nonmacrosomic nondiabetic group (38 ± 1.9 ng/mL) or the nonmacrosomic diabetic group (13 ± 3.5 ng/mL). There was a direct linear correlation between cord serum IGF-I and infant birth weight, independent of diabetes (r² = 0.61, P < .01). On the other hand, IGF-II cord serum levels were elevated in diabetic pregnancies (337 ± 12.2 ng/mL) compared with nondiabetic women (172 ± 19.8 ng/mL), but there was no correlation with birth weight (r² = 0.035, P = .52). In contrast to cord blood levels, IGF-II peptide levels were significantly decreased in the placentas from mothers with diabetes compared with nondiabetic controls (116 ± 3.2 versus 158 ± 5.3 ng/mL, respectively). Levels of IGF-I peptide in placentas from both nondiabetic controls and diabetic mothers were below the sensitivity of the assay. levels of IGF-I and IGF-II mRNA did not differ in placentas from diabetic mothers versus nondiabetic controls.

Conclusion: Cord serum IGF-II levels are elevated in diabetic pregnancies without a concomitant increase in placental IGF-II levels. This novel finding, combined with the finding that IGF-I levels are correlated with macrosomia independent of the diabetic state, contributes to our understanding of the possible mechanisms involved in fetal growth in pregnancies complicated by diabetes.

Key Words: Insulin-like growth factors • macrosomia • maternal diabetes

Journal of the Society for Gynecologic Investigation, Vol. 3, No. 2, 78-84 (1996)
DOI: 10.1177/107155769600300207


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?